Skip to content
Sunday, October 11, 2026
Explore in-depth articles on technology, digital trends, an…

TikTok Influencers Fueling Parallel Trade for Unlicensed Slimming Drug

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Followers are urged to contact these accounts privately for source information, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals injecting substances of uncertain source.

Several professionals said the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.

Service Reaction and Content Removal

According to TikTok, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Trading Operations

Investigations also found communities with up to 9,000 participants selling the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with photos of slimming results, glowing testimonials and step-by-step guides for mixing or administering at residence.

After moments of entering one group, a vendor posted contact information, where most transactions take place. The vendor sent an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Product Details and Pricing

Inside these communities, messages display black plastic packages with Royal Mail labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how long a pen should last, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Actions

A representative for the messaging service said it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may subject patients to possibly serious health risks”.

By

Lindsey Thomas

A tech enthusiast and digital strategist with over a decade of experience in software development and emerging technologies.

TechSphere Blog

Type to search articles.